Jesús Alejandro Pineda Migranas

Mr. Jesús Alejandro Pineda Migranas

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
JMJesús Alejandro Pineda Migranas
Jesús Alejandro Pineda Migranas
JBJuan Carlos Bravata-Alcantara
Juan Carlos Bravata-Alcantara
ICIliana Alejandra Cortés-Ortiz
Iliana Alejandra Cortés-Ortiz
ENOC MARIANO CORTÉS MALAGÓNENOC MARIANO CORTÉS MALAGÓN
ENOC MARIANO CORTÉS MALAGÓN
MRMaria de los Angeles Romero-Tlalolini
Maria de los Angeles Romero-Tlalolini
GAGustavo Acosta-Altamirano
Gustavo Acosta-Altamirano
Cervical cancer remains a significant public health priority, particularly in low- and middle-income countries. In this context, liquid biopsy has emerged as a minimally invasive method for detecting and monitoring molecular biomarkers, offering advantages over traditional screening approaches. This systematic review included 21 studies published between 2015 and 2025 and was conducted in accordance with the PRISMA 2020 statement. The analysis examined the role of serum cytokines, circulating microRNAs (miRNAs), and circulating cell-free HPV DNA (cfHPV-DNA) in patients with cervical cancer or high-grade intraepithelial lesions. Circulating miRNAs—particularly miR-21, miR-29a, and miR-34a—are consistently associated with recurrence, tumor progression, and reduced survival. However, their immediate clinical translation remains limited by methodological variability and the lack of universal normalizers. In contrast, cfHPV-DNA, especially with ddPCR, exhibited the best study-level performance, with a specificity of 100% and a sensitivity of approximately 80–88%, across heterogeneous endpoints and analytic conditions. Consequently, cfHPV-DNA represents a promising tool for post-treatment surveillance and early detection of recurrence. Serum cytokines, such as TNF-α, IL-6, and IL-10, reflect inflammation and the tumor microenvironment. Nevertheless, their lack of standardization and variability across detection platforms restricts their reproducibility, positioning them as complementary rather than stand-alone markers. In conclusion, the evidence supports liquid biopsy as a promising tool in cervical cancer management; nonetheless, only cfHPV-DNA is currently ready for clinical application, whereas miRNAs and cytokines require multicenter validation and technical standardization before implementation.

17 January 2025 in Microorganisms
Verified
Journal Article
Open access
PDF file
ICIliana Alejandra Cortés-Ortiz
Iliana Alejandra Cortés-Ortiz
GAGustavo Acosta-Altamirano
Gustavo Acosta-Altamirano
RNRafael Nambo
Rafael Nambo
JMJesús Alejandro Pineda Migranas
Jesús Alejandro Pineda Migranas
OOscar Giovanni Rios Hernandez
Oscar Giovanni Rios Hernandez
JBJuan Carlos Bravata-Alcantara
Juan Carlos Bravata-Alcantara
Infertility, both primary and secondary, is strongly influenced by microbiological factors, with the vaginal microbiota playing a key role in reproductive health. Objective: The aim of this study was to characterize the vaginal microbiota of 136 Mexican women diagnosed with infertility—primary (n = 58) and secondary (n = 78)—by evaluating the presence of pathogenic bacterial species and their associations with infertility conditions. Methods: Samples were obtained through cervical swabs, and microorganism identification was performed using qPCR techniques. Results: Analysis revealed a positive correlation between increased age and the likelihood of primary infertility, as well as a negative correlation with secondary infertility. Significant differences in microbial composition were also observed between the two infertility groups. Lactobacillus crispatus and Lactobacillus gasseri were dominant in women with primary infertility, in addition to a high prevalence of Gardnerella vaginalis and Fannyhessea vaginae. Additionally, correlations were found between the presence of human papillomavirus (HPV) and sexually transmitted bacteria, as well as Gardnerella vaginalis. Conclusion: Our findings suggest that the composition of the vaginal microbiota may play a decisive role in infertility, highlighting the need for personalized therapeutic strategies based on microbial profiles.

Verified
Journal Article
Open access
PDF file
ICIliana Alejandra Cortés-Ortiz
Iliana Alejandra Cortés-Ortiz
ENOC MARIANO CORTÉS MALAGÓNENOC MARIANO CORTÉS MALAGÓN
ENOC MARIANO CORTÉS MALAGÓN
EGEduardo García-Moncada
Eduardo García-Moncada
GAGustavo Acosta-Altamirano
Gustavo Acosta-Altamirano
JMJesús Alejandro Pineda Migranas
Jesús Alejandro Pineda Migranas
JBJuan Carlos Bravata-Alcantara
Juan Carlos Bravata-Alcantara
The global emergence of multidrug- and pandrug-resistant Klebsiella pneumoniae poses a critical threat to public health, particularly in hospital settings. This study describes a nosocomial outbreak caused by K. pneumoniae in a tertiary-care hospital in Mexico and provides a comprehensive genomic analysis of six clinical isolates. All isolates exhibited pandrug resistance, including carbapenems and colistin. Whole-genome sequencing identified 37 antimicrobial resistance genes, including blaNDM-1, blaOXA-1, blaCTX-M-15, and a pmrB R256G mutation associated with colistin resistance. Two conjugative plasmids (pAA046 and pAA276) carried multiple resistance genes and mobile genetic elements. Although all isolates harbored CRISPR-Cas type I-E systems, no spacers matched resistance plasmids, suggesting functional inactivity. Capsular typing identified the KL27 locus with the wzi187 allele. Phylogenetic and cgMLST analyses confirmed clonal dissemination and close genetic relatedness to strains from Europe and the USA. Despite the absence of classical hypervirulence markers, the presence of kfu, fimH, and mrkD genes indicates adaptation to the hospital environment. These findings confirm the clonal spread of pandrug-resistant K. pneumoniae ST392-KL27 in a Mexican hospital, underscoring the role of plasmid-mediated resistance and the potential for global dissemination.

27 November 2024 in Infectious Disease Reports
Verified
Journal Article
Open access
PDF file
RGRebeca Eunice García-Mendiola
Rebeca Eunice García-Mendiola
MGMaritza Micheli García-Lucas
Maritza Micheli García-Lucas
JMJennifer Morales-Vázquez
Jennifer Morales-Vázquez
RFRaúl Adrián Cruz Flores
Raúl Adrián Cruz Flores
Miguel LoyolaMiguel Loyola
Miguel Loyola
Juan Manuel Bello-LópezJuan Manuel Bello-López
Juan Manuel Bello-López
Background: The current economic and social crisis in Latin America has caused migration to the USA, bringing with it Public Health challenges due to the importation of various infectious diseases. Migrants, particularly those with chronic conditions, such as HIV infection and other sexually transmitted infections (STI), are at greater risk due to pharmacological interruption and access to medical care, so the timely detection of diseases acquired during their migration, such as malaria, is crucial to avoid health complications. Objective: To outline by a multidisciplinary approach (Infectology, Parasitology, Epidemiology, molecular Biology, Venereology, and Public Health) the diagnosis and management of a male case with malaria imported to Mexican territory, HIV chronic infection, and latent syphilis. Methods: A male migrant of Venezuelan nationality attended the Clínica Especializada Condesa Iztapalapa in Mexico City for health complications. A comprehensive analysis of laboratory and molecular tests was performed to confirm HIV infection. During the STI diagnostic algorithm, latent syphilis was detected and microscopic observation of blood smears revealed parasitic forms compatible with malaria. Standard and molecular tests were applied under the operational definition for malaria cases for identification, diagnosis, and treatment. Finally, study of clinical history and migration route by questioning for the investigation of the imported case was performed. Results: The immigrant was diagnosed with HIV chronic-stage infection with interrupted antiretroviral therapy (ART), latent syphilis, and malaria by Plasmodium vivax. The ART administered was chosen based on the possible drug interaction with antimalarials and genetic barrier to the HLA-B* allele. Finally, antimicrobial therapy against syphilis was penicillin. From the analysis of the migratory route, incubation time of imported malaria, and questioning, we speculated that the migrant acquired the P. vivax infection in Panama. Conclusions: This case highlights the complex health problems faced by migrants with HIV infection, particularly when they contract additional infections such as malaria during migration and highlights the need for comprehensive access to healthcare and ART, antimalarial and antimicrobial treatments to mitigate the health risks of this vulnerable population.

Verified
Journal Article
Open access
PDF file
EGEduardo García-Moncada
Eduardo García-Moncada
ENOC MARIANO CORTÉS MALAGÓNENOC MARIANO CORTÉS MALAGÓN
ENOC MARIANO CORTÉS MALAGÓN
JMJesús Alejandro Pineda Migranas
Jesús Alejandro Pineda Migranas
MSMontserrat Ruiz Santana
Montserrat Ruiz Santana
ICIliana Alejandra Cortés-Ortiz
Iliana Alejandra Cortés-Ortiz
JBJuan Carlos Bravata-Alcantara
Juan Carlos Bravata-Alcantara
Human immunodeficiency virus type 1 exhibits extensive genetic diversity, which has important implications for molecular epidemiology, recombinant-pattern assessment, and antiretroviral resistance surveillance. In Mexico, HIV-1 molecular surveillance has historically relied mainly on partial pol gene sequencing, limiting the ability to compare lineage assignments across gag, pol, and env regions. We analyzed plasma samples from 40 treatment-naïve adults receiving care at a tertiary-care hospital in Mexico using a commercial amplicon-based multiregion HIV-1 genomic sequencing workflow. DeepChek® was used as the primary workflow for read processing, mutation calling, region-level subtype assignment, and antiretroviral resistance interpretation. Resistance interpretation was restricted to antiretroviral target regions with sufficient coverage, mainly reverse transcriptase, protease, integrase, and capsid, when available. Drug resistance mutations were identified in 6/40 participants (15.0%) when mutation-level resistance findings in RT, PR, and IN were considered; one additional sample showed a capsid inhibitor-nonsusceptible NGS call. NNRTI-associated findings were identified in 2/40 patients (5.0%), whereas NRTI- and PI-associated findings were identified in 1/40 patients (2.5%). Accessory or secondary INSTI-associated substitutions were detected in 2/40 patients (5.0%). Region-level subtype analysis revealed frequent discordant assignments across amplified segments, which is consistent with complex mosaic profiles; however, these findings are interpreted as region-level subtypes and recombinant-pattern assignments rather than continuous whole-genome recombination maps. One sample had insufficient RT/PROT/INT coverage for drug resistance interpretation in the complete DeepChek report and was retained only for regions meeting quality thresholds. These findings support the value of multiregion HIV-1 sequencing for local molecular surveillance while emphasizing the need for transparent region-level coverage reporting, cautious interpretation of recombinant-pattern calls, and transparent repository reporting.

6 May 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
EGEduardo García-Moncada
Eduardo García-Moncada
ENOC MARIANO CORTÉS MALAGÓNENOC MARIANO CORTÉS MALAGÓN
ENOC MARIANO CORTÉS MALAGÓN
JMJesús Alejandro Pineda Migranas
Jesús Alejandro Pineda Migranas
MSMontserrat Ruiz Santana
Montserrat Ruiz Santana
ICIliana Alejandra Cortés-Ortiz
Iliana Alejandra Cortés-Ortiz
JBJuan Carlos Bravata-Alcantara
Juan Carlos Bravata-Alcantara
Human immunodeficiency virus type 1 exhibits extensive genetic diversity, which has important implications for transmission dynamics, disease progression, and the effectiveness of antiretroviral therapy. In Mexico, molecular surveillance has largely relied on partial pol gene sequencing, limiting the detection of recombination events and resistance mutations outside canonical regions. In this study, we performed near-full-length whole-genome sequencing of HIV-1 from 40 treatment-naïve adults receiving care at a tertiary-care hospital in Mexico to characterize drug-resistance mutations, viral genetic diversity, and recombinant forms. Viral RNA was extracted from plasma and sequenced on an Illumina platform, followed by bioinformatic processing and interpretation using the DeepChek pipeline for subtype classification, recombinant profiling, and identification of drug-resistance mutations. Drug-resistance mutations were identified in 6/40 (15.0%) participants. NNRTI-associated DRMs were identified in 2/40 patients (5.0%), whereas NRTI- and protease inhibitor-associated DRMs were each identified in 1/40 patient (2.5%). In addition, accessory INSTI-associated substitutions were detected in 2/40 patients (5.0%). No statistically significant differences were observed between patients with and without DRMs with respect to age, sex, or plasma viral load. Furthermore, DRMs were distributed across all recombinant categories, with no significant association between recombinant profile and DRM presence (p = 0.97). Non-B subtypes and recombinant forms predominated (82.5%), while subtype B accounted for 17.5% of cases. Extensive intergenic recombination was observed, with discordant subtype assignments across gag, pol, and env regions, consistent with mosaic viral genomes. Multiple circulating recombinant forms, including CRF03_AB, CRF07_BC, CRF28_BF, and CRF39_BF, were identified, alongside a predominance of BF-related recombinants. In addition, several unique recombinant forms with complex mosaic structures were detected, reflecting ongoing recombination and viral evolution. These findings highlight the high genetic complexity of HIV-1 in this population, characterized by a predominance of recombinant forms and extensive genomic mosaicism. The detection of DRMs across diverse genetic backgrounds supports the value of baseline resistance testing and suggests that broader genomic surveillance may improve HIV-1 molecular epidemiology monitoring in Mexico.